Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-16

Clinical Trial Update: Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing ezetimibe/simvastatin (MK-0653A) against rosuvastatin and a doubled statin dose in adults with cardiovascular disease and dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ezetimibe/Simvastatin (MK-0653A) (ezetimibe/simvastatin)
  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Cardiovascular Disorder, Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2012-03-16